Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

ABSTRACTThe emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine a...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Ya-Nan Zhang, Qiu-Yan Zhang, Xiao-Dan Li, Jin Xiong, Shu-Qi Xiao, Zhen Wang, Zhe-Rui Zhang, Cheng-Lin Deng, Xing-Lou Yang, Hong-Ping Wei, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Taylor & Francis Group 2020-01-01
Sraith:Emerging Microbes and Infections
Ábhair:
Novel coronavirus
alkaloid
broad-spectrum antiviral
2019-nCoV
SARS-CoV-2
Rochtain ar líne:https://www.tandfonline.com/doi/10.1080/22221751.2020.1772676

Ar líne

https://www.tandfonline.com/doi/10.1080/22221751.2020.1772676

Míreanna comhchosúla